https://www.avient.com/sites/default/files/2022-05/DOC 1879.pdf
DISTRIBUTION…………………………… 16 10.8 QUALITY CONTROL TESTING………………………………………….. 17
11.0 CONTINUOUS IMPROVEMENT…………………………………………… ........ 17 11.1 FIGURE B.
Hoar Effective Date: May 13, 2022 Title: QF-02 Quality Standard Response Page 17
https://www.avient.com/sites/default/files/2023-11/AVNT November IR Presentation.pdf
FULL YEAR 2023 GUIDANCE $710 $3,130 Q4 FY Sales Adjusted EBITDA Adjusted EPS 17
AVIENT REGIONAL SALES Packaging 27% Consumer 14% Healthcare 5% Industrial 17%
Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17
https://www.avient.com/sites/default/files/2023-06/AVNT June IR Conferences w_Non GAAP Recs.pdf
Mix 19) Inflation (4) SEM: Price / Mix 6) Inflation (4) Net Price Benefit 17
inflation of raw materials, wages and energy U.S. & Canada 40% EMEA 38% Asia 17%
REGIONAL SALES BY END MARKET Packaging 27% Consumer 14% Healthcare 5% Industrial 17%
https://www.avient.com/sites/default/files/2023-03/AVNT Mar 2023 Earnings Presentation.pdf
Safer than Industry Average World-Class Safety Leadership Development Over $17
Inclusion 15 2022 RE SU LT S Q4 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 17
REGIONAL SALES BY END MARKET Packaging 27% Consumer 14% Healthcare 5% Industrial 17%
https://www.avient.com/investor-center/news/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance
Organic revenues increased 17% to $1.16 billion driven by strong demand across
healthcare (up 22%) and consumer products (up 24%) as organic revenue increased 17%
https://www.avient.com/center-of-excellence/avient-asia
Read More
May 17, 2025
https://www.avient.com/center-of-excellence/avient-europe-middle-east-and-africa
Read More
May 17, 2025
https://www.avient.com/sites/default/files/resources/POL%2520Sidoti%2520IR%2520Presentation%2520w%2520Non%2520GAAP%25203%252018%25202014.pdf
double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17
Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
7% - 14%+20% - 11% 2022 2023 (in millions) Q4 EBITDA BRIDGE (TOTAL COMPANY) 17
Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17
https://www.avient.com/sites/default/files/2023-11/AVNT Q3 2023 Earnings Presentation - Website.pdf
Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% 17
Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17